News

Cerenis and Novasep claimed that CER-001 represents a new approach in the fight against atherosclerotic cardiovascular disease and has shown preclinical efficacy in promoting reverse lipid transport. The

Albemarle has posted a net income of $81,751 for the second quarter 2010, or $0.89 per diluted share, compared to $38,493, or $0.42 per diluted share for the

X-Body Biosciences and SRU Biosystems said that they have jointly developed a new BIND Biosensor design for use with the commercially available SRU BIND Reader that results in

Aaron Thomas said that the new ProSys squeeze tube filling line has the capacity to fill upto 60ppm and is also capable of filling metal, plastic and laminate

CSKI said that the internal R&D team of the company has developed the drug based on registration standards of similar imported drugs. CSKI claimed that the drug’s main

Eli Lilly has posted a net income of $1.349bn for the second quarter 2010, or $1.22 per diluted share, compared to $1.159bn, or $1.06 per diluted share, for

Huifeng said that the order is valued at approximately $3.8m with shipments between August 2010 and July 2011. Diosmin, a flavonoid that can be isolated from various plant

Sandoz said that its Enoxaparin has been developed under an agreement signed between Momenta Pharma and Sandoz. Enoxaparin is therapeutically equivalent to the reference-listed drug, Lovenox, which is

Minocycline ER is the generic version of Solodyn ER, a treatment for acne, sold by Medicis. Solodyn is a tetracycline class antibiotic medicine that contains minocycline. It fights